AI clinical consultant platform integrating genomics for primary care physicians
Bioscope AI delivers a cloud-based subscription service pairing whole-genome sequencing with AI reasoning for primary care physicians. The tech stack (PyTorch, Python, RAG, Claude) reflects a genomics + LLM-reasoning architecture; projects center on clinical-grade pipelines (pharmacogenomics, polygenic risk scoring, WGS feature extraction) and uncertainty quantification—suggesting the company is solving for medical-grade AI output quality, not just inference speed. Hiring velocity is accelerating with a data-heavy team (6 of 7 technical hires) tasked with evaluation automation and security controls, indicating product-market fit is driving operational maturation.
Bioscope AI is a healthcare software company founded in 2025, based in Carmel, Indiana, serving primary care physicians in concierge and functional medicine practices. The product is a per-patient subscription service that integrates with physician EMRs and includes whole-genome sequencing in year one. The platform functions as an AI consultant, using genomics data and multi-step reasoning to help physicians deliver personalized, precision-based care. The 11–50 person team is primarily distributed across data science, engineering, marketing, and security, with active hiring underway.
PyTorch, Python, RAG, Claude, React, AWS/GCP/Azure, GitHub Actions, GitLab CI/CD, GATK, and HubSpot. Security tooling includes SentinelOne, SAST, DAST, SOC 2, and NIST frameworks.
Clinical-grade genomics pipelines (pharmacogenomics, polygenic risk scoring, whole-genome sequencing), automated evaluation systems, uncertainty quantification, AI agents for clinical reasoning, and retrieval systems for the platform.
Other companies in the same industry, closest in size